Breast cancer (BC), one of the most widespread and devastating diseases affecting women
worldwide, presents a significant public health challenge. This review explores the emerging …

Breast cancer remains a significant clinical concern affecting millions of women worldwide.
Immunotherapy is a rapidly growing drug class that has revolutionized cancer treatment but …

Standard treatment options for breast cancer include surgery, chemotherapy, radiation, and
targeted therapies, such as adjuvant hormonal therapy and monoclonal antibodies …

Recently, immune edition has been recognized as a new hallmark of cancer. In this respect,
some clinical trials in breast cancer have reported imppressive outcomes related to …

Breast cancer (BC) is globally one of the leading killers among women. Within a breast
tumor, a minor population of transformed cells accountable for drug resistance, survival, and …

Breast cancer affects millions of women worldwide, leading to many deaths and significant
economic burden. Although there are numerous treatment options available, the huge …

Breast cancer is a very heterogeneous disease, both at a molecular and a histological level.
Five intrinsic subtypes were initially identified—Luminal-A, Luminal-B, HER2+, Triple …

Breast cancer is the most commonly diagnosed malignancy and a leading cause of cancer-
related death in women worldwide. It also exhibits pronounced racial disparities in terms of …

The breast cancer tumor microenvironment (TME) is dynamic, with various immune and non-
immune cells interacting to regulate tumor progression and anti-tumor immunity. It is now …

In recent years, the tumor microenvironment (TME) has been a research hotspot, as it is
composed of distinct cellular and non-cellular elements that may influence the diagnosis …